About ProBed Medical Technologies

Related Information

• Contact Pro-Bed Medical Technologies Inc.

ProBed Medical Technologies Inc. is a Canadian company that was established in Abbotsford, British Columbia, in 1989. The challenge at that time was to develop a therapeutic product that would prevent or alleviate some of the complex medical conditions faced by temporarily or permanently immobilized persons.

The result of 12 years of research, development and constant testing is a computer controlled therapy system called the Freedom Bed™. The bed has been designed primarily with the human condition in mind and has been shown in clinical trials and through extensive patient testing to prevent, and assist in the healing of, life-threatening pressure sores (decubitus ulcers) as well as many other medical complications related to immobility

The primary function of the Freedom Bed™ is to slowly and quietly rotate the bed-user from side to side to relieve pressure and re-establish blood flow to compressed tissue. The bed’s computers drive this movement automatically on a customized programmed schedule so that the bed-user does not have to be woken up during the night to be manually turned. The result is an uninterrupted sleep for bed-users and their caregivers.

The cost of providing essential health care to immobilized persons has also driven the development and design of the Freedom Bed™. It is well known within the Health Care System that the primary cause of back, neck and shoulder injuries to nursing and support staff is the repositioning or transfer of immobilized patients. Our bed has been designed to help staff to avoid these injuries by automating many of the patient movements that have been done manually in the past. This has the dual advantage of allowing key staff to avoid lost time through injury and let them focus on other critical needs of their patients.

When you add up the savings from reducing lost staff time, hiring replacement personnel, additional employees to turn patients, compensation claims and the direct medical costs associated with treating medical complications of immobility, it is clear that these savings will rapidly repay the initial investment in ProBed’s technology.